A mutator phenotype characterizes one of two complementation groups in human cells tolerant to methylation damage

Area of Science:

• Cellular toxicology
• DNA repair mechanisms
• Carcinogenesis

Background:

• Methylating carcinogens pose significant risks to cellular DNA.
• Understanding cellular resistance mechanisms is crucial for cancer research.
• HeLa cells are a widely used model for studying cytotoxicity and DNA repair.

Purpose of the Study:

• To investigate the mechanisms of cellular tolerance to methylating carcinogens.
• To characterize the genetic basis of acquired resistance to N-methyl-N-nitrosourea (NMU) in HeLa cells.
• To determine the relationship between DNA damage tolerance and mutation rates.

Main Methods:

• Isolation and characterization of HeLa cell clones resistant to NMU.
• Measurement of O6-methylguanine-DNA methyltransferase (MGMT) activity.
• Cell fusion experiments to analyze complementation groups.
• Mutation rate analysis at microsatellite loci and the hypoxanthine-guanine phosphoribosyl transferase (hprt) gene.

Main Results:

• 60% of NMU-treated HeLa clones exhibited 6- to 100-fold increased resistance to NMU cytotoxicity.
• Resistant clones lacked detectable MGMT activity, indicating tolerance to O6-methylguanine.
• Complementation analysis revealed two distinct groups of tolerant cells.
• Complementation Group I cells showed microsatellite instability and elevated hprt mutation rates (4-8 fold).
• Complementation Group II cells did not display significant changes in spontaneous mutation rates.

Conclusions:

• Cellular tolerance to methylation damage can be mediated by alterations in at least two different gene products.
• One mechanism of tolerance is associated with a mutator phenotype, characteristic of defective mismatch repair.
• These findings highlight the complex interplay between DNA repair, damage tolerance, and mutagenesis.